cellectar biosciences inc
(CLRB:Consolidated Issue listed on NASDAQ Capital Market)
Michael J. Doyle FACHE
Former Director, Cellectar Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 54 board members in 4 different organizations across 6 different industries.|
See Board Relationships
Mr. Michael J. Doyle, also known as Mike, FACHE served as Global Head of Regulatory Affairs at Novella Clinical, Inc. Mr. Doyle has extensive Wall Street experience. Mr. Doyle is accomplished in growing companies rapidly from early stage to acquisition or IPO, and was an early investor in Predictive Networks. Mr. Doyle served as Chief Executive Officer and President of Medsphere Systems Corporation from October 2007 to July 2011. Mr. Doyle served as Chief Executive Officer ...
3301 Agriculture DrivePhone: 608-441-8120
Madison, Wisconsin 53716
Board Members Memberships*
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
The University of Chicago
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|